Genes involved in DNA damage response were differentially up-regulated in the sensitive tumours (FBXO6, RFC5, SOD2) suggesting that preparedness for keeping DNA undamaged promotes sensitivity when encountering a drug that causes DNA damage (CHO) [51-53]. Here, FBXO6 is linked to neoplasm.